Clinical Trial Update: Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial evaluating tobramycin inhalation powder for non-cystic fibrosis bronchiectasis with Pseudomonas aeruginosa; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• Tobramycin Inhalation Powder (tobramycin inhalation powder)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-14